Skip to main content

ZTS

Stock
Health Care
Drug Manufacturers - Specialty & Generic

Performance overview

ZTS Price
Price Chart

Forward-looking statistics

Beta
0.98
Risk
24.37%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.

Company info

SectorHealth Care
IndustryDrug Manufacturers - Specialty & Generic
Employees14K
Market cap$80.7B

Fundamentals

Enterprise value$74.5B
Revenue$9.3B
Revenue per employee—
Profit margin27.12%
Debt to equity145.63

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$5.57
Dividend per share$2.00
Revenue per share$20.56
Avg trading volume (30 day)$432M
Avg trading volume (10 day)$407M
Put-call ratio—

Macro factor sensitivity

Growth-4.0
Credit+7.8
Liquidity+1.2
Inflation-7.3
Commodities-1.8
Interest Rates-1.9

Valuation

Dividend yield1.27%
PEG Ratio25.12
Price to sales7.64
P/E Ratio25.12
Enterprise Value to Revenue8.02
Price to book15.26

Upcoming events

Next earnings dayMay 6, 2025
Next dividend day—
Ex. dividend dayJuly 18, 2025

News

SGIOY or ZTS: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Drugs sector might want to consider either Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) or Zoetis (ZTS).

Zacks Investment Research (July 7, 2025)
How pet medicine stocks could cushion your healthcare investments from Trump changes

Moderna shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investment Management portfolio manager Jason Kritzer shares his perspective on the pharmaceutical industry amid pushback from the Trump administration's Department of Health and Human Services (HHS) Secretary Robert F.

Yahoo Finance (June 2, 2025)
Trade Tracker: Brenda Vingiello sells Zoetis and buys Quanta Services

Brenda Vingiello, Chief Investment Officer at Sand Hill Global Advisors, joins 'Halftime Report' to detail her latest trades.

CNBC Television (May 9, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free